Editorial| Volume 159, 107721, January 01, 2020

An integrated care pathway for cancer patients with diabetes: A proposal from the Italian experience

Published:May 11, 2019DOI:https://doi.org/10.1016/j.diabres.2019.04.036
An integrated care pathway for cancer patients with diabetes: A proposal from the Italian experience
Previous ArticleSeries: Implications of the recent CVOTs in type 2 diabetes
Next ArticleThe effect of Ramadan fasting on cardiovascular events and risk factors in patients with type 2 diabetes: A systematic review

      Abstract

      Diabetes and cancer frequently coexist in the same subject, often with relevant clinical effects on the management and prognosis of the comorbid patient. The existing guidelines, however, do not appropriately address many clinical issues in this setting. Although collaboration between diabetologists and oncologists should play an important role in achieving appropriate levels of care, close coordination or agreement between these specialists is seldom offered. There is an urgent need for greater interdisciplinary integration between all specialists involved in this setting, for a shared approach ensuring that organisational silos are overcome. To this end, the Italian Associations of Medical Diabetologists (AMD) and the Italian Association of Medical Oncology (AIOM) recently established a dedicated Working Group on ‘Diabetes and Cancer’. The working group outlined a diagnostic and therapeutic clinical pathway dedicated to hospitalised patients with diabetes and cancer. In this article, we describe the Italian proposal including some suggested measures to assess, monitor and improve blood glucose control in the hospital setting, to integrate different specialists from both areas, as well as to ensure discharge planning and continuity of care from the hospital to the territory.

      Keywords

      To read this article in full you will need to make a payment
      Purchase one-time access
      Subscribe to Diabetes Research and Clinical Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Vigneri P.
        • Frasca F.
        • Sciacca L.
        • Pandini G.
        • Vigneri R.
        Diabetes and cancer.
        Endocr Relat Cancer. 2009; 16: 1103-1123
        View in Article
        • Psarakis H.M.
        Clinical challenges in caring for patients with diabetes and cancer.
        Diabetes Spectrum. 2006; 19: 157-162
        View in Article
        • Barone B.B.
        • Yeh H.C.
        • Snyder C.F.
        • et al.
        Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis.
        JAMA. 2008; 300: 2754-2764
        View in Article
        • Ballotari P.
        • Vicentini M.
        • Manicardi V.
        • Gallo M.
        • Chiatamone Ranieri S.
        • Greci M.
        • et al.
        Diabetes and risk of cancer incidence: results from a population-based cohort study in northern Italy.
        BMC Cancer. 2017; 17: 703https://doi.org/10.1186/s12885-017-3696-4
        View in Article
        • Sacerdote C.
        • Ricceri F.
        Epidemiological dimensions of the association between type 2 diabetes and cancer: A review of observational studies.
        Diabetes Res Clin Pract. 2018; 143: 369-377https://doi.org/10.1016/j.diabres.2018.03.002
        View in Article
        • Cignarelli A.
        • Genchi V.A.
        • Caruso I.
        • Natalicchio A.
        • Perrini S.
        • Laviola L.
        • et al.
        Diabetes and cancer: Pathophysiological fundamentals of a 'dangerous affair'.
        Diabetes Res Clin Pract. 2018; 143: 378-388https://doi.org/10.1016/j.diabres.2018.04.002
        View in Article
        • Ranc K.
        • Jørgensen M.E.
        • Friis S.
        • Carstensen B.
        Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment.
        Diabetologia. 2014; 57: 927-934https://doi.org/10.1007/s00125-014-3186-z
        View in Article
        • King E.J.
        • Haboubi H.
        • Evans D.
        • Baker I.
        • Bain S.C.
        • Stephens J.W.
        The management of diabetes in terminal illness related to cancer.
        QJM. 2012; 105: 3-9https://doi.org/10.1093/qjmed/hcr167
        View in Article
        • Ford-Dunn S.
        • Quin J.
        Management of diabetes in the terminal phase of life.
        Pract Diab Int. 2004; 21: 175-176
        View in Article
        • McCoubrie R.
        • Jeffrey D.
        • Paton C.
        • Dawes L.
        Managing diabetes mellitus in patients with advanced cancer: a case note audit and guidelines.
        Eur J Cancer Care. 2005; 14: 244-248
        View in Article
        • Quinn K.
        • Hudson P.
        • Dunning T.
        Diabetes management in patients receiving palliative care.
        J Pain Symptom Manage. 2006; 32: 275-286
        View in Article
        • Handelsman Y.
        • Leroith D.
        • Bloomgarden Z.T.
        • Dagogo-Jack S.
        • Einhorn D.
        • Garber A.J.
        • et al.
        Diabetes and cancer - an AACE/ACE consensus statement.
        Endocr Pract. 2013; 19: 675-693https://doi.org/10.4158/EP13248.CS
        View in Article
        • Gallo M.
        • Muscogiuri G.
        • Felicetti F.
        • Faggiano A.
        • Trimarchi F.
        • Arvat E.
        • et al.
        Adverse glycaemic effects of cancer therapy: indications for a rational approach to cancer patients with diabetes.
        Metabolism. 2018; 78: 141-154https://doi.org/10.1016/j.metabol.2017.09.013
        View in Article

      14. AMD-SID. Standard italiani per la cura del diabete mellito 2018. http://aemmedi.it/wp-content/uploads/2009/06/AMD-Standard-unico1.pdf [accessed February 2019].

        View in Article

      15. NHS – Pan Birmingham Cancer Network. Guideline for the Management of Diabetes Mellitus in Palliative Medicine. http://www.uhb.nhs.uk/Downloads/pdf/CancerPbDiabetesMellitus.pdf [accessed February 2019].

        View in Article

      16. Mateo J, Castro E, Olmos D, on behalf of the European Society for Medical Oncology. Cancer treatment in patients with diabetes. From: 2013 ESMO Handbook on Cancer Treatment in Special Clinical Situations: 72–88. Edit. ESMO Press.

        View in Article
        • Gallo M.
        • Gentile L.
        • Arvat E.
        • Bertetto O.
        • Clemente G.
        Diabetology and oncology meet in a network model: union is strength.
        Acta Diabetol. 2016; 53: 515-524
        View in Article

      18. AMD-AIOM Working Group on “Diabetes and Cancer”. http://aemmedi.it/diabete-e-tumori/ [accessed February 2019].

        View in Article

      19. Clemente G, Giorgini M, Mancini M, Gallo M, on behalf of the AMD ‘Diabetes and Cancer’ working group. Diabetologists and Oncologists attitudes towards treating diabetes in the oncologic patient: insights from an exploratory survey. Diabetes Res Clin Pract 2018;143:420–7. http://doi.org/10.1016/j.diabres.2018.02.044.

        View in Article

      20. Rete Oncologica Piemonte-Valle d’Aosta. Protocollo per la gestione del paziente oncologico con diabete mellito. http://www.reteoncologica.it/images/stories/Linee_guida_raccomandazioni_RETE/Terapie_di_supporto/DEF_PZ_ONCO_DIABETE_MELLITO.pdf [accessed February 2019].

        View in Article

      Article Info

      Publication History

      Published online: May 11, 2019
      Accepted: April 30, 2019
      Received: February 12, 2019

      Identification

      DOI: https://doi.org/10.1016/j.diabres.2019.04.036

      Copyright

      © 2019 Elsevier B.V. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2021 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX